Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer
Henan Cancer Hospital
Henan Cancer Hospital
Norwegian Institute of Public Health
Norwegian Institute of Public Health
Vastra Gotaland Region
Vastra Gotaland Region
Vastra Gotaland Region
Başakşehir Çam & Sakura City Hospital
Umraniye Education and Research Hospital
Fundació d'investigació Sanità ria de les Illes Balears
Institute for Clinical and Experimental Medicine
National Hepatology & Tropical Medicine Research Institute
National Cancer Center, Korea
Vastra Gotaland Region
Sheba Medical Center
Anhui Provincial Hospital
Azienda Sanitaria Locale di Asti
Henan Cancer Hospital
Instituto Nacional de Cancer, Brazil
Tuen Mun Hospital
Henan Cancer Hospital
Moscow Regional Oncological Dispensary
ANRS, Emerging Infectious Diseases
Henan Cancer Hospital
University Hospital, Angers
University Hospital, Angers
ANRS, Emerging Infectious Diseases
Fundació d'investigació Sanità ria de les Illes Balears
Nanchong Central Hospital
Nanchong Central Hospital
Henan Cancer Hospital
Henan Cancer Hospital
Nanchong Central Hospital
Nanchong Central Hospital
Nanchong Central Hospital
Nanchong Central Hospital
Sheba Medical Center
Sorlandet Hospital HF
University Hospital, Angers
Fujian Cancer Hospital
Health Institutes of Turkey
Institute of Health Information and Statistics of the Czech Republic
Unidade Local de Saúde São João
Taipei Veterans General Hospital, Taiwan
Queensland Centre for Gynaecological Cancer
Defactum, Central Denmark Region
Fujian Cancer Hospital
Queensland Centre for Gynaecological Cancer
Coordinación de Investigación en Salud, Mexico
Turku University Hospital
Region Stockholm